GP40221
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GP40221, covering 2024-07-11 to 2024-07-11. Get the full timeline:
Most recent: Clinical Trial Update: Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®. [Phase 1]